Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KDM5A | P29375 | 1/20 | 0.34 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL975581 | 1.00 | SMN1; SMN2 (0.50) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL1548270 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL18555812 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL465301 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL465288 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL9329960 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL3932580 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL474236 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL1784204 | 0.97 | LMNA (0.52) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL19595025 | 0.95 | SMN1; SMN2 (0.46) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10113049-B2 | Thermoplastic resin composition | NIPPON NYUKAZAI CO., LTD. (JP) | 2018-10-30 | — | — | US | claimed |
| US-20150329698-A1 | THERMOPLASTIC RESIN COMPOSITION | NIPPON NYUKAZAI CO., LTD. (JP) | 2015-11-19 | — | — | US | claimed |
| US-20080066644-A1 | Alkylmines, alkanolamine compounds, surfactants, a coloring agent and a solvent; combination results in decreased kogation | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-03-20 | — | — | US | claimed |
| EP-1900785-A1 | Ink Composition for Inkjet Recording | Samsung Electronics Co., Ltd. (KR) | 2008-03-19 | — | — | EP | claimed |
| EP-3518874-B1 | METHODS, COMPOSITIONS AND USES RELATING THERETO | INNOSPEC LTD (GB) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023131780-A1 | CORROSION INHIBITOR | INNOSPEC LIMITED (GB) | 2023-07-13 | — | — | WO | disclosed |
| US-11311471-B2 | Methods, compositions and uses relating thereto | INNOSPEC LIMITED (GB) | 2022-04-26 | — | — | US | disclosed |
| US-11253453-B2 | Reducing colour loss from a dyed material by using an amine salt of a carboxylic acid | INNOSPEC LIMITED (GB) | 2022-02-22 | — | — | US | disclosed |
| US-11234917-B2 | Methods, compositions and uses relating thereto | INNOSPEC LIMITED (GB) | 2022-02-01 | — | — | US | disclosed |
| EP-3518873-B1 | METHODS, COMPOSITIONS AND USES RELATING THERETO | INNOSPEC LTD (GB) | 2022-01-05 | — | — | EP | disclosed |
| US-10626341-B2 | Quaternary ammonium compounds as fuel or lubricant additives | INNOSPEC LIMITED (GB) | 2020-04-21 | — | — | US | disclosed |
| US-20200030213-A1 | METHODS, COMPOSITIONS AND USES RELATING THERETO | INNOSPEC LIMITED (GB) | 2020-01-30 | — | — | US | disclosed |
| US-6410150-B1 | Composition for film formation, method of film formation, and insulating film | JSR CORPORATION (JP) | 2002-06-25 | — | — | US | disclosed |
| US-6410151-B1 | Composition for film formation, method of film formation, and insulating film | JSR CORPORATION (JP) | 2002-06-25 | — | — | US | disclosed |
| US-20010018129-A1 | Process for producing silica-based film, silica-based film, insulating film, and semiconductor device | JSR CORPORATION (JP) | 2001-08-30 | — | — | US | disclosed |
| EP-1127929-A2 | Composition for film formation, method of film formation, and silica-based film | JSR Corporation (JP) | 2001-08-29 | — | — | EP | disclosed |
| EP-1122770-A2 | Silica-based insulating film and its manufacture | JSR Corporation (JP) | 2001-08-08 | — | — | EP | disclosed |
| EP-1090967-A2 | Composition for film formation, method of film formation, and insulating film | JSR Corporation (JP) | 2001-04-11 | — | — | EP | disclosed |
| EP-1088868-A2 | Composition for film formation, method of film formation, and insulating film | JSR Corporation (JP) | 2001-04-04 | — | — | EP | disclosed |
| US-4383937-A | Aqueous functional fluid compositions | CINCINNATI MILACRON INC. (US) | 1983-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311471-B2 | Methods, compositions and uses relating thereto | LPO, AOC1, HAO2 | SMN1; SMN2 1324/4885LMNA 501/4885ALDH1A1 163/4885 |
| US-10626341-B2 | Quaternary ammonium compounds as fuel or lubricant additives | DNMT3A, FANCD2, POLD1 | SMN1; SMN2 3140/4885LMNA 3503/4885ALDH1A1 911/4885 |
| US-20200030213-A1 | METHODS, COMPOSITIONS AND USES RELATING THERETO | LPO, CA7, AOX1 | SMN1; SMN2 804/4885LMNA 327/4885ALDH1A1 120/4885 |
| US-11234917-B2 | Methods, compositions and uses relating thereto | LPO, CA7, AOX1 | SMN1; SMN2 804/4885LMNA 327/4885ALDH1A1 120/4885 |
| US-11253453-B2 | Reducing colour loss from a dyed material by using an amine salt of a carboxylic acid | CA9, CA12, CA7 | SMN1; SMN2 303/4885LMNA 1011/4885ALDH1A1 441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.